ANTI-PANCREATIC ISLET CELL ANTIBODY - ANVISA Registration 80213250284

Access comprehensive regulatory information for ANTI-PANCREATIC ISLET CELL ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80213250284 and manufactured by DIASOURCE IMMUNOASSAYS S.A.. The registration is held by PHAREBEE DIAGNOSTICOS COMERCIO IMPORTACAO E EXPORTACAO DE PRODUTOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD., MEDIPAN, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.